In Brief
A viral decoy is the long-sought ligand for a key immunoregulatory receptor family on natural killer cells.
INTRODUCTION

Natural killer (NK) cells are a subset of innate lymphoid cells (ILC)
capable of recognizing an array of pathological target cells. As efficient sentinels responsible for the clearance of cancerous, virus-infected, transplanted, antibody-opsonized, and stressed cells, they discriminate between healthy-self, altered-self, and non-self targets through the integration of balanced signals delivered via multiple families of paired germline-encoded NK cell receptors (NKR) (Raulet and Vance, 2006) . Several NKR families have been described, many of which are grouped together in large genomic regions, such as the natural killer gene complex (NKC). In rodents, most NKR are C-type lectin-like proteins encoded within the NKC. These include the Ly49 (Klra1) receptors, the CD94/NKG2 (Klrd1/Klrc1) receptors, the NKG2D (Klrk1) receptor, and the NKR-P1 (Klrb1) receptors, which interact with genetically-linked C-type lectin-related (Clr/Clec2) proteins (Kirkham and Carlyle, 2014; Raulet and Vance, 2006) .
There exist at least five functional mouse NKR-P1 receptors, three stimulatory isoforms (NKR-P1A,C,F), and two inhibitory isoforms (NKR-P1B,G) (Carlyle et al., 2008; Kirkham and Carlyle, 2014) . Originally described almost 40 years ago (Glimcher et al., 1977) , the NKR-P1 proteins were the first receptors to be identified as selectively expressed by NK cells. Yet to date, NKR-P1C, the prototypical NK1.1 antigen in B6 mice (Glimcher et al., 1977; Koo and Peppard, 1984; Ryan et al., 1992) , and NKR-P1A remain orphan-activating receptors with unknown physiological ligands. On the other hand, the paired NKR-P1F and NKR-P1G receptors recognize overlapping ''self'' Clr (Clec2) ligands to balance signals during NK cell education and effector responses, while the inhibitory NKR-P1B receptor recognizes the broadly expressed self Clr-b (Clec2d) ligand (Carlyle et al., 2004; Chen et al., 2011; Iizuka et al., 2003; Kveberg et al., 2009 been shown to be involved in ''missing-self'' recognition under diverse pathological states (Kirkham and Carlyle, 2014) , including cancer (Carlyle et al., 2004) , genotoxic and cellular stress (Fine et al., 2010) , hematopoietic transplantation , immune escape of primary lymphoma cells , and cytomegalovirus and poxvirus infection Voigt et al., 2007; Williams et al., 2012) , while the remainder of the self Clr ligands remain less well characterized. Among pathogens recognized by NK cells, cytomegaloviruses (CMV) demonstrate co-evolution with their natural hosts, likely due to cycles of natural selection for viral versus host fitness. Since early responses to CMV infection are largely NK cell mediated, these viruses have evolved a diverse array of immunoevasins that antagonize NK cell function. For example, the MCMV m157 decoy immunoevasin binds directly to inhibitory Ly49C/I receptors from certain mouse strains, while the stimulatory Ly49H receptor has been evolutionarily adapted to directly recognize m157 as a foreign antigen, in turn dominantly establishing MCMV resistance in B6 mice (Arase et al., 2002) .
Here, we identify the MCMV m02 family member, m12, as a functional decoy ligand that directly engages the mouse NKR-P1B inhibitory receptor and inhibits NK cell cytotoxicity. Importantly, we also demonstrate that m12 directly interacts with two stimulatory orphan receptors, the prototypical NK1.1 antigen, NKR-P1C, and NKR-P1A. These findings demonstrate an important role for the NKR-P1 receptor family in NK cell-mediated immunity to infection and identify m12 as the first physiological NKR-P1C B6 ligand, almost four decades since its discovery as the prototypical NK1.1 antigen (Glimcher et al., 1977) .
RESULTS
MCMV Encodes an NKR-P1B Decoy Immunoevasin
The murine NKR-P1B ligand, , is rapidly lost in response to cellular infection by diverse viruses Voigt et al., 2007; Williams et al., 2012) . However, MCMV-infected fibroblasts also induce a Clr-b-independent NKR-P1B ligand . To establish whether this was due to a viral immunoevasin, we infected cells with different MCMV strains and used them as stimulators for BWZ.CD3z/NKR-P1B 129 (BWZ.P1B 129 ) reporter cell assays . As shown in Figure 1 , mock-treated NIH 3T3 cells or cells exposed to UV-irradiated MCMV strongly stimulated BWZ.P1B 129 reporter cells, a stimulus that was blocked using Clr-b mAb, while weaker stimulation was observed upon live MCMV Smith infection, which could not be blocked using Clr-b mAb ( Figures 1A-1C) . Thus, live MCMV infection is required to both downregulate host Clr-b and induce an alternative Clr-b-independent ligand.
To confirm that this signal was Clr-b independent, we generated Clr-b-deficient NIH 3T3 cells (NIH 3T3.DClrb) Figure S1C ) and rat fibroblasts (data not shown). Thus, a Clr-b/b 2 m-independent NKR-P1B ligand is induced upon MCMV infection of mouse and xenogeneic rat fibroblasts. Since NKR-P1B is inhibitory, these results suggest that MCMV may encode a decoy immunoevasin. To test this, we analyzed distinct MCMV strains and large genomic deletion mutants to determine whether any isolates lacked the NKR-P1B reporter signal upon infection. The MCMV Smith and MCMV K181 strains both generated strong BWZ.P1B 129 reporter signals; however, none of the mutants tested nor the parental BAC-generated MCMV MW97 strain elicited significant BWZ.P1B 129 reporter responses ( Figures 1F and 1G ). This suggested that MCMV MW97 might possess a polymorphism or loss-of-function mutation that abrogated BWZ.P1B 129 reporter cell recognition.
The MCMV-Encoded m12 Immunoevasin Targets NKR-P1B-Mediated Inhibition
To take advantage of the discrepancy between the MCMV strains, we conducted unbiased whole-transcriptome RNAsequencing (RNA-seq) using MCMV-infected NIH 3T3 cells to identify differences between MCMV Smith and MCMV
MW97
. RNAseq reads were then mapped to the MCMV genome sequence using TopHat analysis and visualized using the IGV browser. Since numerous MCMV immunoevasin genes are located at the left or right genomic termini, such as the m02 and m145 families, we analyzed differences within these regions ( Figures 1H and 1I ). Within the m145 family, few differences in transcript expression or genetic polymorphisms were noted between the two MCMV strains (Tables S1 and S2 ). In contrast, the m02 family displayed significantly more differences in transcript profiles and singlenucleotide polymorphisms (SNP). To screen these alleles functionally, we independently cloned all of the MCMV Smith m02 and m145 family members and some other known immunoevasins (in total, 32 gene products spanning 15% of the MCMV genome) into a mammalian expression vector, and then we tested them individually using human 293T transfectants as stimulators for BWZ.P1B B6 m12 Is a Glycosylated Type I Transmembrane Protein We next characterized the topology, localization, and functional expression of m12. While a transmembrane (TM) domain was identified near the C terminus of m12 ( Figure S2A ), SignalP did not detect an N-terminal signal peptide. However, bioinformatic analyses identified a second in-frame ATG codon that yielded a canonical signal peptide (when analyzed by SignalP) and translational start site (according to the NetStart server). To validate the second ATG translational initiation site, we generated several m12 constructs, including native m12 (m12
) and N-terminal FLAG-tagged m12 with either a native or preprotrypsin signal peptide (m12 NSP-FLAG , m12 PSP-FLAG ). These constructs were then analyzed using 293T transient transfectants, flow cytometry, and BWZ.P1B 129 reporter cell assays (Figures S2B and S2C) . Notably, cell-surface m12 FLAG was detected on transfectants using ATG2 and both signal peptides (m12
PSP-FLAG ), confirming a type I TM topology ( Figure S2B ). In addition, all of the m12 constructs stimulated BWZ.P1B B6 reporter cells, with m12 ATG1 yielding the weakest signal ( Figure S2C ). Collectively, these results suggest that ATG2 is preferred, the native signal peptide is cleaved, and m12 is expressed as a functional type I TM cell-surface protein. To assess m12 biochemically, we conducted immunoprecipitation and western blot analysis of 293T transfectants. Under non-reducing conditions, the m12 protein exists both as a 35-40 kDa monomer and a 60-75 kDa dimer ( Figure S2D ). Under reducing conditions, only a single band of 40 kDa was observed. Enzymatic digestion using endoglycosidase-H (EndoH) revealed a 40 kDa EndoH-resistant band and a 28 kDa EndoH-sensitive band, while treatment with peptide-Nglycosidase-F (PNGaseF) demonstrated a single band at 28 kDa, in accordance with a predicted size of 24.6 kDa. These data suggest that m12 is a highly N-linked glycosylated type I TM protein.
A H B C D E F G
Recognition of m12 by the Prototypical NK1.1 Activating Receptor, NKR-P1C B6 We next tested whether m12 was capable of interacting with paralogous host receptor isoforms and alleles. To this end, BWZ reporter cells bearing CD3z-fusion NKR-P1A/B/C/F/G receptors were constructed from the FVB, B6, and 129/BALB-strain alleles. Notably, the NKR-P1B FVB and NKR-P1C B6 alleles react with NK1.1 mAb, whereas the NKR-P1B 129/BALB alleles do not (Carlyle et al., 1999 (Carlyle et al., , 2006 Ryan et al., 1992) , and NKR-P1A/ B/C forms a separate clade from NKR-P1F/G (Figure 2A ). When BWZ.NKR-P1 reporter cells were stimulated using 293T transfectants of the m12
Smith allele, the stimulatory NKR-P1A, NKR-P1F, and inhibitory NKR-P1G receptors did not appreciably recognize m12 Smith (data not shown), while all inhibitory NKR-P1B receptor alleles recognized m12 Smith (Figures 2B, 2D, and 2F) . Remarkably, the m12 Smith immunoevasin also significantly interacted with the stimulatory NKR-P1C B6 receptor, demonstrating that m12
Smith is a much-anticipated natural ligand for the prototypical NK1.1 antigen (Glimcher et al., 1977; Koo and Peppard, 1984; Ryan et al., 1992 ) ( Figure 2C) . Figure 3A ). As observed using reporter cell assays, m12 recognition was found to be highly allele sensitive, with m12 Smith binding to NKR-P1B 129 and NKR-P1B FVB with affinities 8-fold (K d = 0.7 mM) and 40-fold (K d = 0.15 mM) higher than observed for NKR-P1B B6 ( Figure 3A ). As controls, m12 Smith did not bind to the structurally related Ly49A B6 receptor and m04 did not bind appreciably to any NKR-P1 alleles tested ( Figure 3B ). Notably, binding of m12 Smith to NKR-P1C B6 , but not NKR-P1B B6 , could be blocked using NK1.1 mAb ( Figure 3C ), which only recognizes NKR-P1C
B6
(and NKR-P1B FVB ) but not NKR-P1B B6 ( Figure 3D ) (Carlyle et al., 1999 (Carlyle et al., , 2006 Ryan et al., 1992) . We further generated m12 Smith tetramers and used these to stain transient 293T.NKR-P1 transfectants using an IRES-GFP reporter vector. These m12 tetramers were found to bind directly to cells expressing NKR-P1A B6,129 ,FVB , NKR-P1B B6, 129, FVB , and NKR-P1C B6,FVB , but not NKR-P1C 129 , NKR-P1F, or NKR-P1G ( Figure 3E ). Notably, m12
Smith tetramer staining of the activating NKR-P1A/C receptors was significantly lower than for the inhibitory NKR-P1B receptors at similar IRES-GFP reporter levels, indicating a weaker avidity of m12 Smith for the cellular NKR-P1A/C isoforms. In addition, the m12 Smith tetramers bound to fresh ex vivo B6-strain lymphocyte subsets, which mainly consisted of the NKR-P1B + subset of NK cells, with significantly lower staining observed for the remaining NK cells, NKT cells, and T cells, likely due to the weaker m12:NKR-P1A/C interactions at the cell surface ( Figure 3F S3C and data not shown). Importantly, differences in NKR-P1 tetramer staining levels were observed using distinct NKR-P1 receptors across several m12 variants from distinct MCMV strains; these differences likely reflect their respective avidities for m12 variants at the cell surface (as they follow a similar affinity hierarchy to SPR results, where FVB > 129 > B6 for m12
Smith ; see also below). Collectively, the above results demonstrate that there exists allelic and isoform specificity among the direct m12:NKR-P1A/B/C protein-protein interactions.
Structure of m12
Smith Complexed to NKR-P1B
B6
We next determined the structure of NKR-P1B B6 bound to m12 Smith ( Figure 4 ; Figure S4 ; Table S3 ). NKR-P1B adopted a classical C-type lectin-like domain (CTLD) fold and possessed a compact b3-b4 loop rather than the extended conformation observed in murine NKR-P1A (Kolenko et al., 2011 ) ( Figure S4A ). Overall, m12 adopts an eight-stranded b-sandwich fold comprising one large (AIDEF) and one small (BGHC) b sheet, similar to that described for the m04 immunoevasin (Figures S4B-S4D) (Berry et al., 2014; Sgourakis et al., 2014) . Like m04, the m12 I strand possesses two cysteine residues (Cys168 and Cys173) that form intra-molecular disulfide bonds with the CD loop (Cys88) and A strand (Cys58), respectively. However, m12 also contains an additional disulfide bridge between Cys40-Cys95 that serves to tether the relatively long N-terminal extension to the CD loop ( Figure S4 ). Moreover, m12 possesses an additional a helix between the B and C strands. Thus, m12 possesses unique structural features that are directly involved in NKR-P1B receptor binding. Topologically, m12 lies across the top of the NKR-P1B CTLD, such that the m12 b sheets lie parallel to the interface ( Figure 4A ). Here, m12 straddles NKR-P1B in a claw-like manner, whereby a relatively flat ''palm'' engages the planar top surface of the NKR-P1B CTLD, while several ''fingers'' grasp around the periphery ( Figures 4B-4C ). This binding mode results in an extensive interface that buries a total solvent-accessible surface area of 2,180 Å 2 , which is considerably larger than the 1,680 Å 2 observed upon binding of the KACL endogenous ligand to the human NKp65 receptor (Li et al., 2013) (Figures S4E and S4F) . The interface is characterized by high shape complementarity and is dominated by hydrophilic interactions, including 14 H bonds and 8 salt-bridges ( Figure 4B and Table S4 ). The m12 palm encompasses residues from the A and B strands as well as the interconnecting loop (Ser60-Leu66) that form an extended surface that simultaneously engages the b2-b3 and b4-b5 loops as well as the b4 strand of NKR-P1B. Here, the interaction is stabilized by a number of H bonds that are primarily derived from the m12 and NKR-P1B main chains ( Figures 4C-4D ). In contrast to the flat, featureless palm, the m12 fingers are comprised of multiple large, primarily polar residues that form highly specific interactions around the edges of the docking site ( Figures and 4E-4G). For example, the m12 N terminus contains a highly charged 48 ERR 50 motif that flanks the NKR-P1B CTLD ( Figure 4E ). In addition, the loop region connecting the NKR-P1B b1 sheet to the a1 helix is similarly flanked by a triad of residues (Lys69, Asn73, Val76) that emanate from the unique m12 a1 helix ( Figure 4F ). Further polar interactions are centered on the base of the m12 I strand, where Asp165 and Lys167 extend downward in order to engage Glu200, Asn206, Arg207, and Asn150 ( Figure 4G ). Overall, the breadth and the polar claw style of the interactions with NKR-P1B underlie the capacity of m12 to target this receptor family.
A Single Allelic SNP between m12 Smith/MW97 Impacts NKR-P1B Figure S3B ). We further validated these results using cytotoxicity assays. Here, we generated stable retroviral transductant YAC-1 target cells expressing native m12 Smith , m12
MW97
, or host Clr-b (indexed via IRES-GFP levels; Figure S5A ). As observed using 293T transfectants, BWZ.NKR-P1 reporter analyses using YAC-1 stimulators show that BWZ.P1B B6 cells recognize m12
Smith more strongly than m12 MW97 ( Figure 5C ). In contrast, BWZ.P1B FVB cells recognize m12 Smith and m12 MW97 similarly ( Figure S5B ), suggesting that the energetic profile of the interaction is allele specific. However, we could not detect significant stimulation of BWZ.P1C B6 reporter cells using YAC-1.m12
Smith stimulators ( Figure 5D ), perhaps due to the lower m12 expression levels on these sorted stable transductants; notably, these data are consistent with reduced m12 tetramer staining of NKR-P1A/C relative to NKR-P1B ( Figure 3E Cr-release cytotoxicity assays. As shown in Figure 5 , YAC-1.m12 MW97 target cells were killed equivalently to control YAC-1(-) targets, while both YAC-1.m12
Smith and YAC-1.Clr-b target cells significantly in- hibited NKR-P1B + NK-LAK cell cytoxicity ( Figure 5E ). Importantly, inhibition by m12 Smith and host Clr-b was mediated via NKR-P1B B6 , as it was not observed using NKR-P1B -NK-LAK effectors ( Figure 5F ).
Notably, similar results were observed using sorted FVB-strain NKR-P1B + and NKR-P1B -NK-LAK effectors, partitioned using NK1.1 mAb (PK136), which recognizes NKR-P1B FVB (but not NKR-P1C FVB ) (Carlyle et al., 1999) (Figures S5C and S5D) . The similar recognition of m12
Smith and m12 MW97 using BWZ.P1B FVB reporters ( Figure S5B ) and NKR-P1B FVB tetramers ( Figure S3B ) but strong inhibition of cytotoxicity only by m12
Smith suggests differential recognition of the m12 alleles by other stimulatory receptors, such as the NKR-P1A/C paralogs ( Figure 2H ; see also below). The m12 Smith :NKR-P1B B6 structure provided an opportunity to understand the molecular basis underpinning the highly allelesensitive nature of this pivotal interaction. For example, NKR-P1B 129 differs from NKR-P1B B6 by 16 residues within the CTLD, but only 4 contact m12 Smith (S157R, Y158F, G201S, and S204T). Of these, the S157R and G201S polymorphisms would likely result in additional contacts with m12 Smith and would thereby account for the marked increase in affinity of NKR-P1B 129 compared to NKR-P1B B6 ( Figure 5G ). In addition, the polymorphic m12 residue, E91, did not directly contact NKR-P1B B6 but instead packed tightly against the m12 N terminus, thereby facilitating the interaction of the m12 48 ERR 50 motif with NKR-P1B B6 ( Figure 5G ). Here, the m12 MW97 E91K polymorphism would likely disrupt this packing and would thus indirectly abrogate the m12
Collectively, these data demonstrate that an allelic m12
SNP results in less-efficient NKR-P1B immunoevasin function, while the m12 Smith immunoevasin is capable of effective inhibition of both B6 and FVB NK-LAK effectors using YAC-1 targets. Moreover, the crystal structure provides a molecular basis for understanding the impact of host and viral allelic variation across the m12:NKR-P1B axis.
Wild MCMV Isolates Demonstrate Host-Driven Evolution of the m12 Gene Product The above findings support the existence of both host-and pathogen-driven evolutionary selection pressures, including the lossof-function m12 MW97 SNP. Since NKR-P1B and NKR-P1C are polymorphic between mouse strains, we investigated whether additional m12 polymorphisms also exist in wild-derived MCMV isolates. Thus, we searched databases to compare m12 sequences from additional MCMV strains, including the Smith, K181, MW97.01, WP15B, C4A, C4B, C4C, C4D, G4, AA18d, N1, and NO7 isolates (Smith et al., 2013) ; notably, with Figure 6A ; Figure S6 ).
To assess these functionally, we cloned unique m12 gene products and then tested their recognition using BWZ.NKR-P1 reporters and 293T.m12 transfectant stimulators. We observed differences in recognition among all MCMV m12 alleles when tested against the different NKR-P1B and NKR-P1C alleles ( Figures 6B-6G ). The m12 C4A variant has an
A34V substitution yet engaged all NKR-P1B alleles similarly to m12 Smith ( Figures 6B, 6D , and 6F); this was also true using NKR-P1B tetramers ( Figure S3B ). This result is not surprising, since the most N-terminal m12 residue visible in the structure (S39) is distal to the NKR-P1B binding site ( Figure 5G ). The m12 MW97 variant, as observed previously, has an E91K substitution and engaged NKR-P1B B6 much less efficiently than m12 Smith in both reporter assays and using NKR-P1B tetramers, yet this difference was reduced using the NKR-P1B 129 allele and was absent using the NKR-P1B FVB allele ( Figures 6B, 6D , and 6F; Figure S3B ). The highly diversified m12 G4 variant was not recognized by NKR-P1B B6 , interacted with NKR-P1B 129 similarly to m12 MW97 , and interacted with NKR-P1B FVB less well than other m12 variants ( Figures 6B, 6D , and 6F; Figure S3B ). When tested against the NKR-P1C paralogs, all m12 variants interacted with NKR-P1C B6 to some extent, although m12 G4 recognition was very weak ( Figure 6C ). None of the m12 variants were found to interact with NKR-P1C 129 ( Figure 6E ), which may not be functionally expressed, due to the absence of a key cysteine residue (C122S) likely to be involved in intra-molecular stabilization. In contrast, NKR-P1C
FVB was stimulated strongly Figure 5G ). Interestingly, Clr-b also weakly stimulated NKR-P1C FVB reporters ( Figures 6G and 6H) , demonstrating that host Clr-b represents a novel activating self NKR-P1C ligand in the FVB strain. These data provide further evidence of the existence of host-and pathogen-driven evolution of the viral m12 decoy and reciprocal host adaptation of the NKR-P1B/C paralogs. These findings also validate the hypothesis that the NKR-P1B/C receptors have been co-evolving as a paired receptor clade to recognize similar host and viral ligands.
MCMV Mutants Reveal NKR-P1B-Dependent Inhibition In Vitro and Virulence In Vivo
To establish an immunoevasin role for m12, we generated m12-modified variants of the parental MCMV MW97 strain, including both m12-deficient (Dm12) and m12
Smith -revertant (m12 Smith ) mutants. In vitro characterization revealed that all three MCMV variants similarly downregulated host Clr-b upon infection of NIH 3T3 cells ( Figure S7A ).
Using infected NIH 3T3 cells directly, the m12 , and no stimulation using Dm12 mutant MCMV ( Figure 7B) Figure 7C ). The Clr-b-independent nature of these responses was confirmed using blocking Clr-b mAb (data not shown), as well as using mutant NIH 3T3.DClrb cells infected with each of the MCMV strains ( Figures S7B-S7D ). Together, these data demonstrate that m12 is a non-redundant NKR-P1B decoy immunoevasin and that the m12 G271A SNP (E91K polymorphism) identified between MCMV Smith and MCMV
MW97
is responsible for the differential stimulation of BWZ.P1B reporter cells. Next, we conducted 51 Cr-release cytotoxicity assays using sorted B6-strain NKR-P1B + and NKR-P1B -NK-LAK effectors and MCMV-infected NIH 3T3 targets. Notably, mock, MCMV MW97 , and Dm12-infected NIH 3T3 targets were efficiently lysed, whereas m12 Smith -infected targets displayed significantly lower cytotoxicity in response to NKR-P1B + effectors ( Figure 7D ).
Importantly, inhibition by m12
Smith was NKR-P1B dependent, as it was not observed using NKR-P1B -NK-LAK ( Figure 7E ). These data reveal that m12
Smith , but not m12
MW97
, is directly capable of inhibiting B6-strain NK cytotoxicity in an NKR-P1B-dependent manner upon live MCMV infection.
To evaluate m12 immunoevasin function in vivo, the three variant MCMV MW97 strains were used to infect B6-strain WT,
, and Nkrp1b -/-mice, then MCMV virulence was evaluated 3 days later using plaque assays and quantitative realtime PCR (qPCR) for viral genomic copy numbers in infected spleens. As expected, due to weak interaction between m12 MW97 and NKR-P1B B6 , no significant difference was observed between the parental MCMV MW97 and Dm12 mutant viruses in B6 WT mice in vivo ( Figure 7F) ; remarkably, however, the m12 Smith -revertant virus displayed significantly higher splenic viral titers (PFU) and viral genomic copy numbers in B6 WT mice ( Figures 7F-7G) . Importantly, the enhanced virulence of the m12 Smith allele in vivo was NKR-P1B dependent and
Clr-b independent, as it was not observed using B6-strain Nkrp1b -/-mice ( Figures 7F-7G ), yet Clr-b -/-mice displayed a similar trend to WT B6 mice (data not shown). Notably, increased virulence of MCMV Smith in vivo has been previously observed using WT B6 mice relative to B6.Nkrp1b -/-mice (Rahim et al., 2016 On the other hand, in BALB/c and 129-strain mice, small but significant differences were observed only between the parental MCMV MW97 and Dm12 mutant viruses in vivo, with the m12 Smithrevertant virus showing an intermediate response ( Figure 7I) . Interestingly, the published BALB/c and 129-strain NKR-P1A/ B/C alleles are identical. In keeping with this, we previously observed moderate interactions between the inhibitory NKR-P1B BALB/129 receptor and most m12 alleles ( Figure 6D ), no interactions between the stimulatory NKR-P1C BALB/129 receptor and any m12 alleles ( Figure 6E ), and a weak interaction for the stimulatory NKR-P1A BALB/129 receptor and m12 Smith ( Figures 2H and  3E) Figure 7J ) and BALB.B6 Cmv1r ( Figure 7K ) congenic host strains, relative to the Dm12 mutant and parental m12 MW97 viruses. These data confirm that the superior decoy function of the m12 Smith allele versus the m12 MW97 allele is enhanced in the absence of Ly49H, segregates with the B6-strain NKR-P1 (Klrb1) region, and is unaffected by epistatic effects from the BALB genomic background. Taken together, the above findings demonstrate that the immunoevasin function of m12 in vivo is both host and virus strain dependent, and it can be functionally counterbalanced by both inhibitory and stimulatory NKR-P1A/B/C-clade polymorphisms and paralogs. These findings further confirm that complex interactions between host NKR and MCMV immunoevasins ultimately determine the outcome of host-pathogen interactions in vivo.
DISCUSSION
The NK1.1 (NKR-P1; Klrb1) receptor family comprises both activating and inhibitory members, with a bona fide ligand of the activating NK1.1 antigen remaining unknown, despite being described 40 years ago (Glimcher et al., 1977) . We have identified m12 as a natural (viral) ligand for the prototypical NK1.1 antigen, the stimulatory NKR-P1C B6 orphan receptor (Glimcher et al., 1977; Koo and Peppard, 1984; Ryan et al., 1992) . In addition, host Clr-b represents a second (self) NKR-P1C ligand in the FVB mouse strain. Moreover, we show that m12 functions as a decoy immunoevasin to subvert NK cell-mediated cytotoxicity by direct interaction with the inhibitory NKR-P1B receptor, which normally surveys infected cells for Clr-b downregulation during infection. The identification of the distantly Ig-related m02-family member, m12, as an NKR-P1A/B/C-clade ligand demonstrates sophisticated viral utilization of this protein fold to directly engage an NKR. Structurally, m12 clamped around the NKR-P1B receptor, in a polar claw mechanism, enveloping an extensive area of NKR-P1B that simultaneously provided insight into the specific targeting of the receptor by m12 and how allelic differences in this axis impacted upon recognition. Here, a number of the allelic polymorphisms in both the m12 immunoevasin and NKR-P1 receptors either mapped to the binding site or were in close proximity to it, thereby implying that both direct and indirect effects can impact the m12-NKR-P1 recognition axis.
The m12 footprint overlapped extensively with that observed for binding of the endogenous self ligand, KACL, to the closely related human NKp65 receptor (Li et al., 2013) . Indeed, the utilization of existing binding sites on host receptors/ligands appears to be a common viral immune evasion strategy. Nonetheless, such structural mimicry does not necessarily underpin immunoevasin strategies, as structurally diverse immunoevasins, such as HCMV UL16 and MCMV m152, map to the same sites on ligands for the human and mouse activating NKG2D receptors, respectively (Mü ller et al., 2010; Wang et al., 2012) . Further, some viral immunoevasins, including m157, can adopt unusual and unanticipated binding modes (Berry et al., 2013) . Our work shows how the structurally divergent, viral Ig-like m12 immunoevasin utilizes binding mode mimicry to engage the inhibitory NKR-P1B receptor, which then underpins the ability of m12 to be reciprocally targeted by the structurally related activating NKR-P1A/C family members, in turn countering the m12 immunoregulatory properties.
The rodent Klrb1 genes display considerable polymorphism, being subdivided into two antigenic and phylogenetic clusters in mice and rats: the NKR-P1A/B/C and NKR-P1F/G clades (Carlyle et al., 2008; Kirkham and Carlyle, 2014; Kveberg et al., 2009) . Strikingly, the NKR-P1B and NKR-P1C receptors appear to have undergone parallel divergence characteristic of paired recognition receptors, leading to the hypothesis that they are under selective pressure, within the constraints imposed by both endogenous self ligands and foreign viral ligands. Here, we provide compelling evidence of co-evolution at the host-pathogen interface, with host adaptation of the NKR-P1A and NKR-P1C (NK1.1) stimulatory receptor paralogs to directly recognize the m12 decoy, as well as the existence of wild-derived viral m12 immunoevasin alleles, including loss-of-function alleles, which may have evolved to avert direct NKR-P1A/C-mediated NK cell activation. We also provide strong evidence that m12 is a nonredundant NKR-P1B-targeting immunoevasin in vivo. However, the functional contribution of m12 to the outcome of host-pathogen interactions in vivo is ultimately determined by both the viral m12 and host NKR-P1A/B/C-clade polymorphisms.
For example, each m12 allele may contribute differentially to viral fitness in distinct mouse strains, and what may appear to be a superior immunoevasin in one mouse strain may be counterbalanced by opposing signals from both inhibitory NKR-P1B and activating NKR-P1A/C paralogs in another mouse strain. Our in-depth analyses employing eight inbred, mutant, or congenic mouse strains and three MCMV variants underscore how viral versus host fitness can be significantly impacted by polymorphisms in both the paired host receptors and viral immunoevasin.
The conserved use of decoy immunoevasins by MCMV (m12) and RCMV (RCTL) to subvert NKR-P1B-mediated NK cell immunosurveillance of pathological target cells highlights the role of the NKR-P1:Clr recognition axis in immunity to infectious disease and suggests that similar mechanisms may operate during HCMV infection of human cells Voigt et al., 2007) . Notably, the human NKR-P1A:LLT1 receptor-ligand pair are likely orthologous to some rodent NKR-P1:Clr interactions. NKR-P1A (CD161) is inhibitory and is expressed on 60% of human NK cells (Lanier et al., 1994) , resembling NKR-P1B in function and expression. LLT1 has more restricted expression than Clr-b and is induced in response to PRR agonists and infection Germain et al., 2011; Rosen et al., 2008) . It remains to be determined whether HCMV may similarly target the human NKR-P1A receptor.
The NK1.1 antigen was the prototypical receptor identified to be selectively expressed by NK cells. Thus, while being used as a tool to study and purify NK cells for almost four decades, the physiological ligand for the activating NK1.1 antigen has remained a mystery. Here, we showcase m12 as a natural virally encoded ligand for this important NKR family. Moreover, NK1.1 is also found on some ILC and various T cell subsets, including invariant NKT cells, the ubiquitous mucosalassociated invariant T (MAIT) cells, CD4 + T helper cells, and activated CD8 + T cells. Thus, targeting of the NK1.1 antigen by a virally encoded ligand has important implications for both innate and adaptive immunity, virus-host co-evolution, and immunotherapy.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals C57BL/6 (B6) mice were purchase from the Jackson Laboratory, FVB/N (FVB) and 129S6 (129) mice were purchased from Charles River. We have previously described the B6.Nkrp1b -/-and B6.Clrb -/-mice Rahim et al., 2015) . B6.Ly49h -/-and Balb.B6-Cmv1 r mice have previously been described (Fodil-Cornu et al., 2008; Scalzo et al., 1995) . All animals were maintained according to approved protocols at the respective institutes: Sunnybrook Research Institute, University of Ottawa, and the University of Rijeka.
Viruses MCMV (Smith strain), MCMV-GFP, and MW97.01 (BAC-generated strain) have all been previously described .
MCMV
Smith and MCMV-GFP were provided by Dr. Silvia Vidal (McGill University). The MCMV K181 strain was provided by Dr. Michael G. Brown (University of Virginia). The Dm12 mutant virus and m12
Smith -revertant viruses were constructed using BAC technology that has previously been described (Wagner and Koszinowski, 2004) .
Cells NIH 3T3, YAC-1, and HEK293T cells were purchased from the American Type and Culture Collection (ATCC). BWZ.36 cells were obtained from N. Shastri (UC Berkeley, CA, USA). B6 mouse embryonic fibroblasts (MEF) were obtained from T.W. Mak (University of Toronto, Canada). Cells were cultured in complete DMEM-HG, supplemented with 2 mM glutamine, 100 U/mL penicillin, 100 mg/ml streptomycin, 50 mg/mL gentamicin, 110 mg/mL sodium pyruvate, 50 mM 2-mercaptoethanol, 10 mM HEPES, and 10% FCS. Cells were maintained in incubator at 37 C, 5% CO 2 . Sf9 and Hi5 cells were cultured in Insect-XPRESS medium (Lonza) at 27 C and maintained with shaking at 120 rpm. HEK293S GnTi-adherent cells were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep/Glutamine (GIBCO) at 37 C in the presence of 5% CO2. For protein expression, FBS was reduced to 2%.
METHOD DETAILS
Virus infections
All viruses were passaged using MEF cells, and purified according to described protocols . For in vitro infections, mouse fibroblasts were infected with MCMV at an MOI of 0.5 PFU/cell, centrifuged at 800xg for 30 min, and incubated at 37 C. For in vivo infections, mice were infected intraperitoneally with 0.2-1x10 6 PFU and sacrificed on day 3, tissues harvested, and the viral titers were assessed using plaque-forming assays .
Flow cytometry and antibodies
Flow cytometry was performed as previously described . Clr-b mAb (4A6) has previously been described (Carlyle et al., 2004) . The NKR-P1B B6 mAb and hybridoma (2D12) were a kind gift from Drs. Koho Izuka and Wayne Yokoyama (Iizuka et al., 2003) . All other mAb clones were purchased from eBioscience or Sigma-Aldrich and are has follows: NK1.1 (PK136); NKp46 (29A1.4); CD3ε (145-C11); FcgRII/III (2.4G2); CD49b/DX5 (clone DX5); gdTCR (clone GL3); FLAG (M2); streptavidin, SA-PE/APC (Thermo Fisher Scientific). The CD1d-tetramer loaded with PBS-57 (aGalCer analog) was a kind gift from Dr. Thierry Mallevaey. For tetramerization, purified biotinylated monomers (m12 Smith , NKR-P1B B6, 129, FVB ) were incubated with SA-PE in a 4:1 molar ratio, aliquoted in 1/10 th volumes over a 3 hr period at 4 C. Cells were stained in flow buffer (HBSS, 0.5% BSA and 0.03% NaN 3 ) on ice with primary monoclonal antibodies for 25-30 min, or secondary streptavidin conjugates for 15-20 min, washed between incubations and then analyzed using a FACSCalibur or FACSCanto II flow cytometer, or FACS sorted using a FACSAria (BD Biosciences). For staining of ex vivo splenocytes or NKp46 + CD3 -lymphokine-activated killer (NK-LAK) effectors, cells were pre-incubated with 2.4G2 mAb for 10 min on ice prior to staining with antibodies. Cells were stained with tetramers by incubating on ice for 1 hr. Cells were analyzed by live gating for FSC/SSC, doublet excluded, exclusion of propidium iodide or DAPI for viability, and then according to cell surface markers. Flow cytometry files were analyzed using FlowJo software.
BWZ Reporter Cell Assays
The ectodomains of the mouse NKR-P1 genes were PCR amplified from day 6 LAK cDNA (see Table S5 for primers) and cloned into a type-II MSCV vector to make chimeric receptors with intracellular CD3z domains. MCMV m12/CD3z chimeric reporters were constructed by cloning the ectodomain of m12 into a type-I MSCV vector . Retroviruses produced with these constructs were used to transduce BWZ.36 cells, and then sorted for IRES-GFP + expression. All reporters were sorted to have matched GFP expression. Reporter assays were done by co-culturing reporter cells (5x10 4 ) with serially diluted amounts of stimulators in 96-well plates. Stimulators used were either MCMV-infected, mock-infected, or cells transfected with plasmids using Lipofectamine 2000 (Thermo Fisher Scientific). Positive control cells were stimulated with 10 ng/mL PMA plus 0.5 mM ionomycin. These cells were incubated overnight, washed with PBS, then resuspended in 150 mL of 1X CPRG buffer (90 mg/L chlorophenol-red-b-Dgalactopyranoside (Roche), 9 mM MgCl2, 0.1% NP-40, in PBS), incubated at room temperature, then analyzed using a Varioskan microplate reader (Thermo Fisher Scientific), using OD 595-655.
51
Chromium release cytotoxicity assays Splenic lymphokine-activated killer (LAK) effector cells were generated by harvesting spleens from mice, processing into single cell suspensions, ACK lysed (Thermo Fisher Scientific), then grown in 10% complete RPMI 1640 media supplemented with 2500 U/mL human rIL-2 (Proleukin; Novartis). On day 4, these cells were FACS sorted for NKp46 +
CD3
-NK cells subsetted based upon NKR-P1B B6/FVB (2D12 or NK1.1 mAb) expression, and used as effectors in 51 Cr-release assays on day 6 or 7. Target cells were labeled with 50 mCi Na 2 51 CrO 4 (Perkin Elmer) in FCS for 1 hr at 37 C, washed, plated in 96-well V-bottom plates in serial dilutions with effector cells at corresponding ratios, and incubated at 37 C for 4 hr. Supernatants (100 ml) were then transferred to scintillation plates (LumaPlate-96; Perkin Elmer), dried overnight, and counted using a Top Count NXT microplate Scintillation Counter (Packard Instrument Company). Percent specific lysis values were calculated relative to standard maximum release (2% Triton X-100) and spontaneous release (media) values.
Generation of NIH 3T3.DClr-b cells using CRISPR-Cas9 technology The pX458 vector was utilized in accordance with Dr. Zhang's protocol for generating targeting vectors (www.genome-engineering. org/crispr/). The sequence of oligos used for constructing Clec2d targeting vector were: sense: 5 0 -cac cgC TAC CTA TGC TTA GTC CCA C-3 0 ; anti-sense: 5 0 -aaa cGT GGG ACT AAG CAT AGG TAG c-3 0 . This vector was transfected into NIH 3T3 cells that were then sorted for GFP + Clr-b -expression. These cells were then subcloned using limiting dilution. Appropriate clones were selected lacking Clr-b cell surface staining and BWZ.NKR-P1B reporter stimulation.
Protein expression and purification
Codon optimized genes encoding NKR-P1 receptors and m12 were synthesized by Integrated DNA Technologies. For NKR-P1B B6 , the unpaired cysteine residue at position 118 was replaced with a glycine. The ectodomains (residues 89-215) of NKR-P1B B6, 129, FVB and NKR-P1C B6 were cloned into a modified pHLSec vector upstream of a biotinylation site and a His tag (for SPR) or a His tag (for crystallization), and expressed via transient transfection in HEK293S cells as described previously (Berry et al., 2013; Berry et al., 2014) . For a single 6000 cm 3 roller bottle, 600 mg plasmid DNA was mixed with 900 mL PEI (1 mg/ml) and 50 mL serum-free DMEM media. This mixture was added to HEK293S GnTi-cells after a 10 min incubation, followed by the subsequent addition of a further 200 mL DMEM and FCS to give a final concentration of 2%. Media was harvested after 3 and 6 days. DNA encoding m12
Smith (residues 29-208) was ligated into the pFastbac vector (ThermoFisher Scientific) upstream of a 6x Histidine tag and used to generate recombinant baculovirus according to the manufacturer's instructions. Specifically, the plasmid was transformed into DH10Bac E.coli cells in order to produce bacmid DNA. Recombinant baculoviruses were generated by transfection of Sf9 cells using Cellfectin 2. Protein was expressed in Hi5 insect cells by the addition of 2% P3 virus, and harvested after 48-72h. Cell culture media containing secreted m12 or NKR-P1 receptors was concentrated by tangential flow filtration and purified using nickel affinity and size exclusion chromatography using HisTrap and Superdex 200 columns 16/60 (GE Healthcare) respectively. For biotinylation, purified NKR-P1 receptors were buffer exchanged into 10 mM Tris and biotinylated overnight at 20 C prior to removal of free biotin via size exclusion chromatography. For SPR experiments, m12 protein was used immediately following purification. However, samples stored at 4 C at high concentration were prone to proteolytic degradation, resulting in a loss of 4 kDa of mass from the carboxy-terminus, as judged by SDS-PAGE analysis. This truncated form of m12 could be selectively purified from the intact molecule by nickel affinity chromatography and bound to NKR-P1 receptors with the same affinity as the entire m12 ectodomain (data not shown). Accordingly, this truncated form of m12 was used for crystallization experiments. The ectodomains of Ly49A B6 and m04
Smith were produced in HEK293SGnTi-cells as described for NKR-P1 above and previously (Berry et al., 2013; Berry et al., 2014) .
Surface plasmon resonance (SPR)
SPR experiments were performed at 25 C on a Biacore 3000 using a running buffer consisting of 10 mM Tris pH8 containing 150 mM NaCl and 0.005% P20. Approximately 800 response units of biotinylated NKR-P1/Ly49 receptors were coupled on to streptavidin-coated chips according to the manufacturer's instructions (GE Healthcare). Remaining free streptavidin sites were blocked with D-biotin. m12 (0.025-50 mM) or m04 (100 mM) was injected over the immobilized receptors at a flow rate of 20 ml/min and the final response was calculated by subtraction of the response of an 'empty' flow cell (containing biotin blocked streptavidin). For blocking experiments, 50 mM m12
Smith was passed over immobilized NKR-P1B B6 and NKR-P1C B6 both before and after injection of 30 mL of 10 mg/ml NK1.1 (clone PK136-StemCell Technologies, Inc.). Equilibrium data were analyzed in GraphPad Prism.
Crystallization and data collection For crystallization, the m12 Smith and NKR-P1B B6 ectodomains were mixed in a 1:1 molar ratio at a final protein concentration of 6.5 mg/ml. Crystals were obtained by the hanging drop vapor-diffusion method from a solution containing 41% PEG 400, 0.1 M Bis/Tris pH 6.3 and 0.4 M sodium iodide at 20 C. Crystals were flash cooled using liquid nitrogen and X-ray diffraction data were recorded on a Quantum-315 CCD detector at the MX2 beamline of the Australian Synchrotron. Data were integrated using iMOSFLM and scaled using SCALA from the CCP4 program suite. Details of the data processing statistics are given in Table S3 .
Structure determination and refinement The structure was solved by molecular replacement using the Phaser program. The initial search model comprised a truncated form of the NKR-P1A CTLD (PDB ID: 3M9Z) that lacked the extended loop located between the b3 and b4 strands. The resulting unbiased electron density was not sufficient to build m12 de novo. However, molecular replacement using an extensively truncated fragment of m04 (PDB ID: 4PN6) comprising only the I, D, E' and F strands improved the quality of the electron density map to an extent that allowed the remainder of the m12 molecule to be built. The structure was refined using Buster. Model building was performed in Coot, and figures were prepared with Pymol (http://www.pymol.org) and APBS. Details of the refinement statistics are provided in Table S4 .
DNA/RNA Isolation, cDNA synthesis and PCR cloning Genomic DNA was isolated using Easy-DNA kit (Thermo Fisher Scientific). RNA was isolated using Total RNA isolation kit with gDNA removal (Norgen Biotek) and reverse transcription reactions were done using Superscript III cDNA synthesis kit (Thermo Fisher Scientific). Quantitative RT-PCR was performed on a CFX-96 PCR Detection System (Bio-Rad) using 20-50 ng of cDNA, and PerfeCTa qPCR mix (Quanta Biosciences). The primers used can be found in Table S5 .
PCR cloning of m02 and m145 family members was done using gene-specific primers with appropriate restriction enzyme sites, cDNA from MCMV-GFP infected NIH 3T3, amplified with Q5 high-fidelity PCR system (New England Biolabs), and cloned into the pIRES2-EGFP vector (Clontech). The summary of primers can be found in Table S5 . The m12 C4A gene was synthesized by conducting in situ mutagenesis using primers found in Table S5 . The m12 G4 gene was synthesized using GeneArt services from Thermo Fisher Scientific (Burlington, ON). Cloning of the Nkrp1 genes was mediated by PCR using gene specific primers (Table S5) .
Immunoprecipitations and Western Blotting N-terminally FLAG-tagged constructs of m12 were generated using primers in (Table S5 ) and cloned into pIRES2-EGFP vector. These constructs were transfected into either HEK293T or NIH 3T3 cells and immunoprecipitations were done using anti-FLAG mAb bound to Protein A/G agarose beads in 1% NP-40 buffer. The isolates were run on SDS-PAGE and transferred to Immobilon PVDF membrane (EMD Millipore) and blotted for anti-FLAG-HRP conjugated antibody (Cell Signal Technologies) and developed with Immobilon ECL reagent. Blots were imaged using a MicroChemi 4.2.
RNA-Sequencing and Analysis
Total RNA from either mock-infected, MCMV-GFP, or MW97.01-infected NIH 3T3 cells using mirVana kit (Thermo Fisher Scientific). These samples were quality checked using an Agilent Bioanalyzer 2100 and confirmed to have RNA integrity values of > 9, then used to create a cDNA library for SOLiD RNA-Sequencing. For analysis of viral transcripts, raw data was mapped onto the MCMV Smith reference genome (accession number GU305914) using TopHat algorithm and Cufflinks was applied to report RPKM values. Mapped reads were visualized using the Integrative Genomics Viewer (IGV version 2.3.34, Broad Institute, https://www.broadinstitute.org/igv/).
Bioinformatic analysis
Mapped RNA-Seq reads were loaded visualized on the IGV Genome Browser using the MCMV Smith reference genome (accession number GU305914). Membrane topology was determined using the TMpred server (http://www.ch.embnet.org/software/ TMPRED_form.html). The SignalP 4.1 Server (http://www.cbs.dtu.dk/services/SignalP/) was used for identification of predicted signal peptides. Detection of ORF start site was achieved using the NetStart 1.0 Prediction Server website (http://www.cbs.dtu. dk/services/NetStart/).
QUANTITATION AND STATISTICAL ANALYSIS
Data were analyzed using GraphPad Prism 7, using either a paired Student's two-tailed t test, or one-way/two-way ANOVA, where applicable. See figure legends for details. Statistical significance is defined as: * p < 0.05; ** p < 0.01; *** p < 0.001.
DATA AND SOFTWARE AVAILABILITY
Coordinates for the m12:NKR-P1B structure have been deposited in the protein data bank (PDB: 5TZN). The accession numbers for the FVB-strain sequences, Nkrp1 splice variants, and m12 variants reported in this paper are GenBank: KX443605-GenBank: KX443630.
